1.68
price down icon1.75%   -0.03
 
loading
Precedente Chiudi:
$1.71
Aprire:
$1.72
Volume 24 ore:
170.24K
Relative Volume:
0.75
Capitalizzazione di mercato:
$27.00M
Reddito:
-
Utile/perdita netta:
$-8.29M
Rapporto P/E:
-2.40
EPS:
-0.7
Flusso di cassa netto:
$-6.47M
1 W Prestazione:
+0.00%
1M Prestazione:
+20.00%
6M Prestazione:
+51.35%
1 anno Prestazione:
-23.64%
Intervallo 1D:
Value
$1.65
$1.75
Intervallo di 1 settimana:
Value
$1.54
$1.78
Portata 52W:
Value
$0.94
$2.3499

NanoViricides Inc Stock (NNVC) Company Profile

Name
Nome
NanoViricides Inc
Name
Telefono
203-937-6137
Name
Indirizzo
1 Controls Drive, Shelton, CT
Name
Dipendente
7
Name
Cinguettio
@nnvcnyse
Name
Prossima data di guadagno
2025-05-20
Name
Ultimi documenti SEC
Name
NNVC's Discussions on Twitter

Confronta NNVC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NNVC
NanoViricides Inc
1.68 27.48M 0 -8.29M -6.47M -0.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

NanoViricides Inc Stock (NNVC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2015-02-11 Iniziato Midtown Partners Strong Buy

NanoViricides Inc Borsa (NNVC) Ultime notizie

pulisher
Jul 26, 2025

Why NanoViricides Inc. stock attracts strong analyst attentionStrong Buy Recommendations - Metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

What drives NanoViricides Inc. stock priceConsistently outstanding ROI - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about NanoViricides Inc. stockExtraordinary earning power - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Is NanoViricides Inc. a good long term investmentFree Trend-Following Techniques - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Is NanoViricides Inc. stock a growth or value playFree Stock Chart Pattern Guide - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

NanoViricides Discusses the Multi-Billion-Dollar Potential of Its Broad-Spectrum Drug NV-387; Its Effectiveness Against Influenza, Coronaviruses, RSV, MPox and Now Measles Expected to Drive Value - Greenville Online

Jul 24, 2025
pulisher
Jul 23, 2025

About Us - FinancialContent

Jul 23, 2025
pulisher
Jul 23, 2025

NanoViricides eyes revenue opportunities with broad-spectrum antiviral NV-387 - Proactive financial news

Jul 23, 2025
pulisher
Jul 23, 2025

NanoViricides (NNVC) Highlights Potential of Antiviral Drug NV-3 - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Multi-Billion Dollar Opportunity: NanoViricides' New Drug Fights COVID, Flu, RSV and Measles with Single Treatment - Stock Titan

Jul 23, 2025
pulisher
Jul 23, 2025

NanoViricides Inc. Stock Analysis and ForecastHigh-octane gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

How NanoViricides Inc. stock performs during market volatilityFree Consultation - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Measles Now Has a DrugNV-387 Broad-Spectrum Antiviral Successful in Animal Studies, says NanoViricides - Lohud

Jul 22, 2025
pulisher
Jul 21, 2025

NanoViricides says lead antiviral boosted survival in measles-infected mice - Proactive financial news

Jul 21, 2025
pulisher
Jul 21, 2025

Breakthrough: New Drug NV-387 Could Be First-Ever Treatment for Measles as Global Cases Surge - Stock Titan

Jul 21, 2025
pulisher
Jul 17, 2025

Mpox Antiviral Clinical Trial Advances as WHO Extends Global Emergency - Global Biodefense

Jul 17, 2025
pulisher
Jul 16, 2025

WHO Extended Global Emergency Status of MPox EpidemicDevelopment of Treatment for MPox with NV-387 is Timely, Says NanoViricides - Pocono Record

Jul 16, 2025
pulisher
Jul 16, 2025

NanoViricides Advances MPox Treatment Development Amid WHO's Extended Health Emergency - citybuzz -

Jul 16, 2025
pulisher
Jul 16, 2025

NanoViricides says MPox drug candidate NV-387 poised for Phase II trial as WHO extends global health emergency - Proactive financial news

Jul 16, 2025
pulisher
Jul 16, 2025

D.C. United Roofing Inc. Wins 2025 Consumer Choice Award for Roofing in Barrie - The Palm Beach Post

Jul 16, 2025

NanoViricides Inc Azioni (NNVC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):